A new startup named Generation Lab has emerged with an ambitious claim: they have developed an injectable treatment that could potentially reverse aging effects in humans. This treatment, referred to as ‘Generation,’ consists of a combination of two existing drugs designed to rejuvenate the bloodstream, activate the body’s repair mechanisms, and restore vitality across various tissues. Generation Lab is currently inviting a select group of individuals to participate in a private cohort to test this therapy under the supervision of qualified medical professionals. The buzz surrounding the treatment has garnered attention from numerous high-profile individuals, all eager to explore its possibilities.
The excitement stems from the company’s scientific founder, Irina Conboy, who has a notable background in the field of aging research. Conboy has previously conducted experiments involving the circulatory systems of young and old lab animals, a practice known as parabiosis. This controversial yet scientifically intriguing method has shown that young blood can rejuvenate older animals, sparking interest in identifying ways to replicate these effects without direct blood exchange. Conboy asserts that her latest drug combination achieves similar benefits, offering a more practical solution for potential age-related decline.
However, the claims surrounding Generation’s drug have raised concerns among experts. While some insiders, including Conboy and CEO Alina Su, report feeling improvements in energy and overall well-being after using the treatment, skepticism remains. The two drugs involved have not been disclosed, which complicates the credibility of the claims. Critics point out that previous attempts at developing age-reversal therapies have faced significant hurdles, and the scientific community is cautious given the lack of peer-reviewed evidence supporting Generation’s assertions. As the startup prepares for a larger study involving more participants, many are left wondering if this will lead to tangible breakthroughs in longevity medicine or if it is merely another case of overhyped promises in the realm of anti-aging treatments.
Source: A startup claims it’s found a drug to make your blood young via MIT Technology Review